Biocept Inc (NASDAQ:BIOC)
| 1.16 Delayed Data As of Aug 12 |  -0.04 / -3.33%Today’s Change | 0.84 Today|||52-Week Range 4.44 | -67.96% Year-to-Date |
Latest BIOC News | Press Releases
| RVL Pharmaceuticals PLC (RVLP) Reports Q2 Loss, Tops Revenue Estimates Aug 11 / Zacks.com - Paid Partner Content | OncoCyte (OCX) Reports Q2 Loss, Misses Revenue Estimates Aug 10 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.20 |
| Today’s open | 1.17 |
| Day’s range | 1.16 - 1.18 |
| Volume | 1,449 |
| Average volume (3 months) | 102,075 |
| Market cap | $23.4M |
Data as of 3:59pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | +87.29% |
| Earnings growth (this year) | -294.74% |
| Earnings growth (next 5 years) | +40.00% |
| Revenue growth (last year) | +123.04% |
| P/E ratio | NM |
| Price/Sales | 0.87 |
| Price/Book | 0.62 |
Competitors
Data as of 4:00pm ET, 08/12/2022
Financials
| Next reporting date | August 15, 2022 |
| EPS forecast (this quarter) | -$0.16 |
| Annual revenue (last year) | $61.2M |
| Annual profit (last year) | -$2.8M |
| Net profit margin | -4.61% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
